UIC Researchers Uncover a Revolutionary Target to Combat Metastatic Cancer
In a groundbreaking discovery, researchers at the University of Illinois Chicago (UIC) have identified a molecular switch that could be the key to unlocking new cancer treatment strategies. This research, led by Assistant Professor Ekrem Emrah Er, sheds light on the complex relationship between cancer cell physics and metastasis, offering a promising therapeutic target.
The study, published in the journal Developmental Cell, reveals that the physical properties of cancer cells play a crucial role in their ability to spread. Er explains, 'The outer shell of a tumor is rigid, but the individual cells inside are soft and flexible, allowing them to leak out and metastasize.' This unique characteristic makes it challenging for the immune system to attack and destroy cancer cells.
What makes this finding even more intriguing is the discovery of the ion channel protein KCNMB1. By activating this pathway, researchers can increase cell stiffness, making cancer cells more susceptible to immune cell attack. This is a significant advancement, as it provides a practical drug target for cancer treatment.
The research team's approach is innovative, focusing on the downstream effects of the protein MRTFA. They identified KCNMB1 as a key player in controlling cell stiffness, and by reducing its expression, cancer cells became softer, while enhancing its activity made cells stiffer. This discovery is particularly appealing because ion channels are already common pharmaceutical targets, with drugs already available to treat cardiovascular diseases.
The study's findings were further supported by animal model experiments. The drug BMS-204352, a potassium-channel activator, reduced distant tumor growth and improved the ability of immune cells to kill cancer cells. This suggests that the treatment enhances immune recognition of metastatic cells, providing a promising strategy for fighting metastasis.
Er emphasizes the significance of this discovery, stating, 'It gives us another front to fight against cancer - a biophysical front.' The research highlights the importance of understanding the physical properties of cancer cells and their impact on metastasis, offering a new perspective on cancer treatment.
While further research is required before clinical trials can begin, this study opens up exciting possibilities for the future of cancer therapy. The UIC researchers' innovative approach and their focus on the unique physical characteristics of cancer cells could lead to groundbreaking advancements in the fight against metastatic cancer.
